A Study of HRS-5346 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

Study of Plozasiran in Adults With Severe Hypertriglyceridemia

NCT06347016 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia

NCT06347003 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events

NCT05537571 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

NCT05563246 ·Status: COMPLETED ·Phase: PHASE2

SB-480848 In Subjects With Coronary Heart Disease

NCT00269048 ·Status: COMPLETED ·Phase: PHASE2

A Study of DII235 in Adults With Elevated Lipoprotein(a)

NCT07235046 ·Status: RECRUITING ·Phase: PHASE2

A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities

NCT01715818 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk

NCT02991118 ·Status: COMPLETED ·Phase: PHASE3

Impact of Sarpogrelate in the Function of Endothelial Progenitor Cells

NCT01548274 ·Status: UNKNOWN ·Phase: NA

BGB-DXP604 Alone and in Combination With BGB-DXP593 in Healthy Participants

NCT04669262 ·Status: COMPLETED ·Phase: PHASE1

Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease

NCT03070782 ·Status: COMPLETED ·Phase: PHASE2

Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance

NCT00733174 ·Status: UNKNOWN ·Phase: PHASE4

Pioglitazone in Impaired Glucose Tolerance

NCT00306826 ·Status: WITHDRAWN ·Phase: PHASE4

A Study to Evaluate Safety and Efficacy of IBI306, a PCSK9 Monoclonal Antibody in Chinese Subjects With Homozygous Familial Hypercholesterolemia

NCT04031742 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

NCT01975376 ·Status: TERMINATED ·Phase: PHASE3

Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction

NCT04806893 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Trial to Evaluate the Efficacy and Safety of DR10624 in Patients With Hypertriglyceridemia and Carotid Atherosclerotic Plaque

NCT07050134 ·Status: ENROLLING_BY_INVITATION ·Phase: NA

A Phase II Clinical Study of SB-480848 in Dyslipidemic Patients

NCT00734032 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of LCQ908 on Cardiovascular Risk

NCT01474434 ·Status: TERMINATED ·Phase: PHASE2

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

NCT07157774 ·Status: RECRUITING ·Phase: PHASE3

Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

NCT04023552 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis

NCT06880770 ·Status: RECRUITING ·Phase: PHASE3

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

NCT01975389 ·Status: TERMINATED ·Phase: PHASE3

Lipid Biomarkers for Diabetic Heart Disease

NCT01752842 ·Status: COMPLETED ·Phase: NA

Phase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 Tablets in Chinese Healthy Volunteers

NCT04036656 ·Status: UNKNOWN ·Phase: PHASE1